“…Amyloid fibril generation is also important for AMP activities, mediating disruption of microbial cell membranes (Sood et al, 2008), neutralization of bacterial endotoxins (Wang et al, 2014), and pathogen agglutination and entrapment (Chu et al, 2012; Torrent et al, 2012). However, dysregulated AMP oligomerization can also lead to serious pathologies, including inflammation, tissue degeneration (Paulsen et al, 2002; Pereira et al, 1996; Reinholz et al, 2012; Scarpa et al, 2012), and deposition as amyloid in at least three human amyloidopathies (Araki-Sasaki et al, 2005; Ciornei et al, 2006; Kee et al, 2008; Linke et al, 2005; Millucci et al, 2011; Pálffy et al, 2009; Reinholz et al, 2012; Scarpa et al, 2012; Yamaguchi et al, 2007; Zhao et al, 2008). Thus, AMP oligomerization carries a potential for protective/damaging duality in human health.…”